Sanara MedTech Inc. — Director's Dealing 2021

Dec 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2021-12-22

Reporting Person: Carmena J Michael (Director, Principal Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-22	Common Stock	A	3549	—	Acquired	22113	Direct

Footnotes

F1: Represents restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Long-Term Incentive Plan, as amended and restated. The shares will vest on January 3, 2022.